Collection of Samples for the Clinical Evaluation of the Aptima HBV (Hepatitis B Virus) Quant (Quantification) Assay

Exclusion Criteria

• •Subject is in one of the following patient populations:
• •* Acute HBV infection
• •* Patients who are HBV immune tolerant
• •* Human immunodeficiency virus (HIV) and/or hepatitis C virus (HCV) co-infection
• •* Solid organ or bone marrow transplant recipients
• •* Renal failure or dialysis
• •* Evidence or history of hepatic decompensation
• •* Evidence or history of hepatocellular carcinoma
• •Underlying liver disease other than HBV
• •Receiving chemotherapy, immunosuppressive agents
• •Subject is unsuitable for study participation based on the Investigator's decision (eg, unlikely to comply with study visit schedule, significant medical complication)
• •Participating in another investigational study that the Investigator believes might interfere with the subject's participation in this study